谷歌浏览器插件
订阅小程序
在清言上使用

An Ongoing Pilot Study of Targeted Radioimmunotherapy (131-I Apamistamab) Conditioning Prior to CD19-Targeted CAR T-Cell Therapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Blood(2022)

引用 0|浏览22
暂无评分
关键词
targeted radioimmunotherapy,acute lymphoblastic leukemia,t-cell,b-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要